Alerts

Possible microbial contamination in some bottles.

Recall notice

The product is being recalled because the tablets do not conform to the uniformity of content specification. This means that some tablets contain the active ingredient in doses much higher than should be there, creating the risk of unintentional overdosing.

The product is being recalled following a number of reports of excess side effects related to the active ingredient.

Packs of Dramamine Junior 25mg Tablets 10s with batch number 0099A may contain 50mg tablet blister inside them.

One or more Nightime tablets may be incorrectly positioned in the Daytime section of the blister pack.

Bottles in this lot may be contaminated with capsules that contain bee pollen.

Recovery of wrongly supplied goods pursuant to Section 30 of the Therapeutic Goods Act 1989.

Calmo drops

Possible microbial contamination in some bottles.

BotanicLab herbal supplements contain undeclared prescription drugs and are not registered in Australia. Stop using them and consult your doctor for advice.

Do not use homoeopathic meningococcal 'vaccines' as they don't protect against the disease. Use approved vaccines and talk to your doctor if you have any questions.

Kava-containing medicines are under review due to reports of liver damage, and a voluntary recall has been initiated while we assess their safety.

Recovery of wrongly supplied goods pursuant to Section 30 of the Therapeutic Goods Act 1989.

We are advising that long-term use of oestrogen-only therapy may increase the risk of ovarian cancer. Consult your doctor if you have concerns.

Possible microbial contamination in some tubes.

The Expert Committee has reviewed the safety of HRT and found increased risks of heart attacks, strokes, blood clots, and breast cancer, outweighing the benefits for long-term disease prevention

A limited number of scooters may experience premature failure of the drive mechanism. In the event of failure loss of drive and braking occurs.

The product has been supplied without being included on the Australian Register of Therapeutic Goods. The product also contains Yohimbine, a substance not approved for supply in Australia.

Consumers are advised to be cautious with kava-containing medicines due to potential liver damage, and should seek medical advice if they experience any symptoms.

Health professionals are alerted to potential liver damage linked to kava-containing medicines, and are asked to review cases of unexplained hepatotoxicity.

This product is being recalled, due to the detection of aristolochic acids by the Therapeutic Goods Administration Laboratories. Aristolochic acids have been associated with serious adverse reactions including severe kidney damage and urinary tract cancer.

These products are being recalled, due to the detection of aristolochic acids by the Therapeutic Goods Administration Laboratories. Aristolochic acids have been associated with serious adverse reactions including severe kidney damage and urinary tract cancer.

Medicine recall

Study on sunscreens with potential estrogen-like effects.